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R4 2020 – Lewiston, ME
Preceptor: Kara Callahan, MD
Slide 2. Problem Identification
• Sharp increase in HAV in 2020 in Maine compared to previous years
• 39 cases in first half of 2020 compared to 7-10 cases per year
• 2019 also had a large increase in cases – 45 cases total
• At least 21 cases in 2020 had risk factors of injection drug use or 
housing insecurity
• During my time at Central Maine Medical Center Family Medicine 
Residency in Lewiston, ME, saw many patients with housing 
insecurity – and therefore could benefit from HAV prevention
Slide 3. Public Health Costs
• In 2018, 1/3 of those that contracted HAV in Maine were hospitalized
• Unable to find data on exact costs in Maine with regards to recent 
outbreak
Slide 4. Community perspective and support 
for project
• Kara Callahan, MD (preceptor) and several family medicine residents
• Residents said that they were unaware of the HAV outbreak in recent 
years
• Residents expressed that they were unsure of the indications for HAV 
vaccination
• One resident explained that it would be helpful to have a smart phrase for 
patient education
• Dr. Callahan provided information of clinic pharmacist, who did not respond 
to request for input
Slide 5. Intervention & Methodology
• Creation of printable, easy-to-read HAV information sheet for 
providers with list of groups in which the vaccine is recommended
• Creation of editable “dot phrase”/smart phrase for providers to edit 
and implement as they see fit
• Sent info sheet and dot phrase to preceptor to disburse to providers
• Plan to present these resources at resident didactics session
Slide 6. Results
• “Dot phrase” as below:
• .HAVedu:
• You have received _1 out of three of the vaccines to 
protect against Hepatitis A. You will return in _1 month 
for the next vaccine.  Completing all three vaccines will 
protect you from Hepatitis A, a disease of the liver. You 
may have an increased chance of getting the disease or 
are more likely to have serious complications from it. 
The most common side effects from the vaccine are 
tiredness, headache, decreased appetite, and 
redness/swelling/pain around the injection site. Please 
ask your doctor any questions about the vaccine or 
about hepatitis. 
Slide 7. Evaluation of effectiveness and 
limitations
• Evaluation of effectiveness may be assessed by rates of provider 
prescription of HAV vaccination after presentation of information 
and printing of info sheet around the clinic
• Limitations include provider buy-in and implementation of routine 
HAV vaccination for adults
Slide 8. Recommendations for future 
interventions/projects
• Potential future interventions could include
• Outreach to known housing-insecure patients to encourage immunizations
• Include HAV vaccination when screening for other liver diseases such as 
Hepatitis C, autoimmune hepatitis, or evaluating for alcoholic liver disease
• Ask parents of children receiving HAV vaccine at well child visit if they are also 
interested in receiving the vaccine 
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